Optomed (private company)

See something wrong or missing? Let us know
Offices:Oulu
Business model:B2B

Optomed Oy is a Finnish medical technology company that specializes in retinal imaging devices and solutions.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Optomed

Name Criteria
France AbolerIS Pharma
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
United Kingdom Abzena
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
United Kingdom Achilles Therapeutics
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
Germany Adrenomed AG
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
Denmark AFYX Therapeutics
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
Spain Algenex
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
Denmark Antag Therapeutics
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
Belgium Antelope Dx
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
Norway APIM Therapeutics
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
Sweden Aprea Therapeutics
40%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1

News about Optomed


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Top